Insights

Expanding Oncology Portfolio Glenmark Pharmaceuticals has actively launched new cancer treatments, including the recent launch of Eribulin Mesylate and tislelizumab, while securing significant rights deals like the $1.1 billion agreement with Hengrui for Trastuzumab Rezetecan. This indicates a strong focus on expanding its oncology portfolio, creating opportunities to offer supportive products, complementary therapies, and clinical partnership solutions to hospitals and specialty clinics.

Strategic Collaborations The company's recent collaborations, such as the exclusive licensing deal with Hengrui Pharma and its partnership with Goldenmean, highlight its openness to strategic alliances in key markets. This presents a sales opportunity to pitch auxiliary services like distribution channels, marketing collaborations, and pharmacy network integration for partners looking to expand their reach in oncology and specialty medicines.

Global Market Presence With operations across over 80 countries and a diverse range of branded generics, Glenmark offers potential sales avenues for medical devices, packaging solutions, and regional distribution services to deepen its reach in emerging markets and developed countries, particularly in dermatology, respiratory, and oncology segments.

Focus on Innovation and R&D Glenmark's investment in research through the formation of Ichnos Glenmark Innovation, focusing on biologics and small molecule cancer therapies, suggests an openness to innovative healthcare solutions, including biosimilars, clinical research services, and advanced manufacturing solutions that can support their R&D initiatives.

Sustainability and CSR Engagements The company's strong emphasis on sustainability, ESG goals, and community engagement opens opportunities for partnering on environmentally friendly packaging, green operations, and CSR-driven health awareness campaigns in untapped regions or new markets within South-East Asia and beyond.

Similar companies to Glenmark Pharmaceuticals

Glenmark Pharmaceuticals Tech Stack

Glenmark Pharmaceuticals uses 8 technology products and services including Bunny, Drupal, oEmbed, and more. Explore Glenmark Pharmaceuticals's tech stack below.

  • Bunny
    Content Delivery Network
  • Drupal
    Content Management System
  • oEmbed
    Dev Tools
  • Microsoft Outlook
    Email
  • GSAP
    Javascript Frameworks
  • Flickity
    Javascript Libraries
  • imagesLoaded
    Javascript Libraries
  • Google Maps
    Maps

Media & News

Glenmark Pharmaceuticals's Email Address Formats

Glenmark Pharmaceuticals uses at least 1 format(s):
Glenmark Pharmaceuticals Email FormatsExamplePercentage
First.Last@glenmarkpharma.comJohn.Doe@glenmarkpharma.com
85%
FirstL@glenmarkpharma.comJohnD@glenmarkpharma.com
13%
First.Middle@glenmarkpharma.comJohn.Michael@glenmarkpharma.com
1%
FirstLast@glenmarkpharma.comJohnDoe@glenmarkpharma.com
1%

Frequently Asked Questions

Where is Glenmark Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Glenmark Pharmaceuticals's main headquarters is located at Glenmark House, B.D.Sawant Marg, Chakala, Andheri (East) Mumbai, Maharashtra 400099 IN. The company has employees across 6 continents, including AsiaNorth AmericaSouth America.

What is Glenmark Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Glenmark Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Glenmark Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Glenmark Pharmaceuticals's official website is glenmarkpharma.com and has social profiles on LinkedIn.

How much revenue does Glenmark Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of October 2025, Glenmark Pharmaceuticals's annual revenue is estimated to be $5B.

What is Glenmark Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign icon
Glenmark Pharmaceuticals's SIC code is 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Glenmark Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of October 2025, Glenmark Pharmaceuticals has approximately 14K employees across 6 continents, including AsiaNorth AmericaSouth America. Key team members include Ceo: R. K.Ceo: M. N.Cfo: J. K.. Explore Glenmark Pharmaceuticals's employee directory with LeadIQ.

What industry does Glenmark Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Glenmark Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Glenmark Pharmaceuticals use?

Minus sign iconPlus sign icon
Glenmark Pharmaceuticals's tech stack includes BunnyDrupaloEmbedMicrosoft OutlookGSAPFlickityimagesLoadedGoogle Maps.

What is Glenmark Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Glenmark Pharmaceuticals's email format typically follows the pattern of First.Last@glenmarkpharma.com. Find more Glenmark Pharmaceuticals email formats with LeadIQ.

Glenmark Pharmaceuticals

Pharmaceutical ManufacturingMaharashtra, India10001+ Employees

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. 

In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products.  Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. 

We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. 

We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ 

Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

Section iconCompany Overview

Headquarters
Glenmark House, B.D.Sawant Marg, Chakala, Andheri (East) Mumbai, Maharashtra 400099 IN
Phone number
SIC Code
5122 - Drugs, Drug Proprietaries, and Druggists' Sundries
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
10001+

Section iconFunding & Financials

  • $1B$10B

    Glenmark Pharmaceuticals's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Glenmark Pharmaceuticals's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.